Submission Procedures

All IIS applications are processed as follows:

1. Applicant reviews the entire content of the ViroPharmagrants.com IIS website.
2. Applicant selects the product or investigational compound that will be the subject of the IIS research.
3. Applicant completes the ViroPharma Investigator Initiated Studies (IIS) Application and submits to the IIS Coordinator
   
4. IIS Coordinator ensures that the Applicant has correctly completed all components of the application and then forwards the Request to the applicable product or investigational compound IIS Committee for review and approval
   
5. IIS Coordinator notifies Applicant whether grant has been approved or denied. Approval is on a conditional basis, subject to the execution of an Agreement, in a form acceptable to ViroPharma.
6. If application is approved, the IIS Coordinator oversees the process of generating a written agreement between ViroPharma and the applicable requesting organization.
7. Upon contract execution, IIS Coordinator arranges for issuance of payment(s) and/or drug supply as per contract requirements.
8. ALL MATTERS RELATING TO INVESTIGATOR INITIATED STUDIES (IIS) MUST BE DIRECTED TO AND HANDLED BY THE IIS COORDINATOR.